Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Nature Reviews. Endocrinology|May 22, 2021
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersLaurence Amar, Karel Pacak, Olivier Steichen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
European Journal of Endocrinology|May 3, 2024
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH studyMiguel Sampedro-Nuñez, Aura Dulcinea Herrera-Martínez, Alejandro Ibáñez-Costa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Nature Reviews. Endocrinology|May 22, 2021
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersLaurence Amar, Karel Pacak, Olivier Steichen, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
European Journal of Endocrinology|May 3, 2024
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH studyMiguel Sampedro-Nuñez, Aura Dulcinea Herrera-Martínez, Alejandro Ibáñez-Costa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
Pageof 22